CP-060

CAS No. 180090-15-7

CP-060( —— )

Catalog No. M32859 CAS No. 180090-15-7

CP-060 is a potent Ca2+ antagonist and inhibits Ca2+ overload with antioxidant and cardioprotective activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 907 Get Quote
5MG 1131 Get Quote
10MG 1520 Get Quote
25MG 2199 Get Quote
50MG 2962 Get Quote
100MG 3915 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CP-060
  • Note
    Research use only, not for human use.
  • Brief Description
    CP-060 is a potent Ca2+ antagonist and inhibits Ca2+ overload with antioxidant and cardioprotective activities.
  • Description
    CP- 060 is a potent Ca2+ antagonist, inhibits Ca2+ overload and possesses antioxidant and cardioprotective activities.
  • In Vitro
    CP-?060 (0.5, 5 μM) inhibits rabbit LDL oxidation induced by soybean lipoxygenase by 12.9% and 3.0%, respectively.
  • In Vivo
    CP-?060 (100 mg/kg, i.v.) increases the coronary blood flow by 96% in anesthetized dogs.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    180090-15-7
  • Formula Weight
    542.73
  • Molecular Formula
    C30H42N2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCN(CCOC=1C=C2C(=CC1)OCO2)C)N3C(C4=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C4)SCC3=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kato T, et al. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones. J Med Chem. 1998 Oct 22;41(22):4309-16.?
molnova catalog
related products
  • TPC2-A1-P

    TPC2-A1-P is a membrane-permeable two-pore channel 2 (TPC2) agonist that differentially activates two-pore channel 2 (TPC2) and mimics the activation of TPC2 with NAADP and PIP(2). TPC2-A1-P can be used to study neurodegenerative lysosomal storage diseases.

  • Flosatidil

    Flosatidil is a small molecule voltage-gated calcium channel complex (VDCCs) blocker for the treatment of neurological disorders and cardiovascular diseases, and can be used in the study of angina pectoris.

  • CALP3

    Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site. Activates phosphodiesterase in the absence of Ca2+ and inhibits Ca2+-mediated cytotoxicity and apoptosis (IC50 = 33 μM).